|
|
Article: Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products to Pfizer.
- Article from:
- Vaccine Weekly
- Article date:
- September 24, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Schering-Plough Corporation (NYSE:SGP) announced the successful closing of its previously announced transaction with Pfizer Animal Health, to divest certain animal health products from selected franchises in the European Economic Area to Pfizer. These divestments were requested by the European Commission as part of its October 2007 clearance of the acquisition of Organon BioSciences N.V. Pfizer has acquired these assets for approximately euro 116 million in cash (see also Bioscience).
With this announcement, Schering-Plough has now successfully completed all product divestments required by the commitments made to the European Commission in connection with its ...